Vanguards of Health Care by Bloomberg IntelligenceVanguards of Health Care by Bloomberg Intelligence

Elicio’s Broad Cancer-Vaccine Ambitions

View descriptionShare

Initial clinical trial data highlight the potential for a new approach to cancer vaccines to treat patients with a wide range of KRAS mutations, Elicio Therapeutics CEO Robert Connelly explains. In this episode of the Vanguards of Health Care podcast, Connelly joins Bloomberg Intelligence biotech analyst Marc Engelsgjerd for a discussion of Elicio’s novel, lymph node-targeting vaccine platform, the company’s recent transition to the public markets via a reverse merger and the biotech scene in Boston’s booming Seaport district, where Elicio is based.  

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Vanguards of Health Care by Bloomberg Intelligence

    42 clip(s)

Vanguards of Health Care by Bloomberg Intelligence

Vanguards of Health Care is a series of exclusive conversations with management teams and thought le 
Social links
Follow podcast
Recent clips
Browse 42 clip(s)